Clinical Trial Update: Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the impact of an integrase inhibitor on HIV-1 latency and the viral reservoir; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Integrase inhibitor

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: HIV-1, HIV Infections | Phase 2 | Status: COMPLETED